Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Jun 12, 2015HiFiBiO to present platform at next-generation antibodies conferenceJun 12, 2015HiFiBiO partners with Johnson & Johnson Innovation< 1 … 15 16 17
